ResearcherUniversity of PittsburghActive in the last 2 years
Sowmya Narayanan
Matched on ORCID iD 0000-0002-0725-9731; OpenAlex author ID A5040888412. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 3
- Impact of Neoadjuvant Therapy on Oncological Outcomes of Patients With Distal Pancreatic Adenocarcinoma. Co-author DOI 10.1002/jso.27856↗
- Response to "Prognostic factors in patients with pancreatic ductal adenocarcinoma with neoadjuvant treatment and pancreatectomy". Co-author DOI 10.1002/jso.26853↗
- Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma. Co-author DOI 10.1002/jso.26510↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alessandro Paniccia · 3 shared papers, 2021–2024 · strength 0.64
- Paper Response to "Prognostic factors in patients with pancreatic ductal adenocarcinoma with neoadjuvant treatment and pancre… DOI 10.1002/jso.26853↗
- Paper Impact of Neoadjuvant Therapy on Oncological Outcomes of Patients With Distal Pancreatic Adenocarcinoma. DOI 10.1002/jso.27856↗
- Paper Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adeno… DOI 10.1002/jso.26510↗
- Asmita Chopra · 2 shared papers, 2021–2024 · strength 0.32
- Amer H. Zureikat · 2 shared papers, 2021–2024 · strength 0.32
- Samer S. AlMasri · 2 shared papers, 2021–2024 · strength 0.32
- Ibrahim Nassour · 2 shared papers, 2021–2024 · strength 0.32
- Hussein H. Khachfe · 1 shared paper, 2024 · strength 0.20
- Anthony Gebran · 1 shared paper, 2024 · strength 0.20
- Aatur Dilip Singhi · 1 shared paper, 2024 · strength 0.20
- Caroline J. Rieser · 1 shared paper, 2021 · strength 0.11
- David L. Bartlett · 1 shared paper, 2021 · strength 0.11
- Nathan Bahary · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.